机译:人细胞色素CYP17A1:17-羟孕酮的裂解酶活性受损的结构基础
Department of Chemistry, Marquette University, Milwaukee, Wisconsin 53233, United States;
Department of Biochemistry, University of Illinois at Urbana−Champaign, 505 S. Goodwin, Urbana, Illinois 61801, United States;
Department of Biochemistry, University of Illinois at Urbana−Champaign, 505 S. Goodwin, Urbana, Illinois 61801, United States;
Department of Biochemistry, University of Illinois at Urbana−Champaign, 505 S. Goodwin, Urbana, Illinois 61801, United States;
Department of Biochemistry, University of Illinois at Urbana−Champaign, 505 S. Goodwin, Urbana, Illinois 61801, United States,Department of Chemistry, University of Illinois at Urbana−Champaign, Urbana, Illinois 61801, United States;
Department of Chemistry, Marquette University, Milwaukee, Wisconsin 53233, United States;
机译:人类CYP17A1的双重活动和与抗前列腺癌药物阿比特龙的结合的机制由一种新型V366M突变引起17,20裂解酶缺乏症揭示。
机译:活性位点质子传递和人CYP17A1的裂解酶活性
机译:细胞色素b(5)通过增加NADPH消耗量与雄激素产生的耦合来激活人细胞色素P450 17A1的17,20-裂解酶活性
机译:黄酮和黄酮醇对人类细胞色素P450 1A1表达的调节-结构要求
机译:人类细胞色素P450酶的结构和功能:CYP2A的异生物代谢和CYP17A1的甾体生物合成
机译:人细胞色素CYP17A1。 17-羟孕酮影响裂解酶活性的结构基础
机译:人的细胞色素CYP17A1:具有17-羟丙基酯的受损裂解酶活性的结构基础